CorVel Co. (NASDAQ:CRVL) Shares Acquired by US Bancorp DE

US Bancorp DE lifted its holdings in shares of CorVel Co. (NASDAQ:CRVL) by 225.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 384 shares of the business services provider’s stock after buying an additional 266 shares during the quarter. US Bancorp DE’s holdings in CorVel were worth $43,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Boston Trust Walden Corp raised its stake in shares of CorVel by 196.8% during the 4th quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider’s stock worth $76,775,000 after buying an additional 457,538 shares during the period. State Street Corp raised its stake in shares of CorVel by 0.8% during the 3rd quarter. State Street Corp now owns 360,068 shares of the business services provider’s stock worth $117,703,000 after buying an additional 2,959 shares during the period. Geode Capital Management LLC raised its stake in shares of CorVel by 3.9% during the 3rd quarter. Geode Capital Management LLC now owns 253,870 shares of the business services provider’s stock worth $83,000,000 after buying an additional 9,571 shares during the period. Bank of New York Mellon Corp raised its stake in CorVel by 184.2% in the 4th quarter. Bank of New York Mellon Corp now owns 183,447 shares of the business services provider’s stock valued at $20,410,000 after purchasing an additional 118,888 shares during the last quarter. Finally, Principal Financial Group Inc. raised its stake in CorVel by 210.2% in the 4th quarter. Principal Financial Group Inc. now owns 139,836 shares of the business services provider’s stock valued at $15,558,000 after purchasing an additional 94,751 shares during the last quarter. 51.36% of the stock is owned by institutional investors and hedge funds.

CorVel Stock Performance

NASDAQ CRVL opened at $105.79 on Wednesday. The business has a fifty day moving average price of $112.09 and a 200 day moving average price of $114.20. CorVel Co. has a one year low of $76.20 and a one year high of $128.61. The company has a market cap of $5.43 billion, a P/E ratio of 62.23 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analyst Ratings Changes

Separately, StockNews.com downgraded CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

Insider Buying and Selling at CorVel

In other CorVel news, Director Steven J. Hamerslag sold 10,000 shares of the company’s stock in a transaction on Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the sale, the director now directly owns 314,000 shares in the company, valued at $38,772,720. This represents a 3.09 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Brandon O’brien sold 1,523 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total value of $182,089.88. Following the completion of the sale, the chief financial officer now owns 17,142 shares of the company’s stock, valued at approximately $2,049,497.52. The trade was a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,200 shares of company stock worth $3,824,115 in the last three months. 47.57% of the stock is owned by corporate insiders.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.